Free Trial

NovaBay Pharmaceuticals (NBY) News Today

NovaBay Pharmaceuticals logo
$1.65 +0.10 (+6.45%)
As of 04:00 PM Eastern

NBY Latest News

NovaBay Pharma Announces Special Cash Dividend
NBY NovaBay Pharmaceuticals, Inc. - Seeking Alpha
NovaBay Pharmaceuticals approves liquidation plan
NovaBay Pharmaceuticals Inc NBY
NovaBay Pharmaceuticals To Sell Assets Of Its Avenova Brand - Quick Facts
NOVABAY PHARMAC. DL-,01 (B9P0.MU)
NovaBay Pharmaceuticals: Q4 Earnings Insights
NioBay Metals closes option agreement to acquire Foothills property
Get NovaBay Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for NBY and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NBY Media Mentions By Week

NBY Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NBY
News Sentiment

0.80

1.03

Average
Medical
News Sentiment

NBY News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NBY Articles
This Week

2

0

NBY Articles
Average Week

Get the Latest News and Ratings for NBY and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for NovaBay Pharmaceuticals and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NYSE:NBY) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners